About Us
Medical Devices and Pharma LLC is a professional provider of expert regulatory consulting services for manufacturers of medical devices and pharmaceutical products regulated by the United States Food and Drug Administration (FDA), Health Canada, the European Union (EU), and globally.
Our website not only provides regulatory information and assistance, but it is also a consumer-oriented resource designed to present timely safety news, helpful information, and analysis for users of medical devices and pharmaceutical products.
Our Mission
The mission of Medical Devices and Pharma is to provide the highest quality personalized professional regulatory services to our clients.
We maintain vigilance and provide timely safety information to consumers of medical device and pharmaceutical products, and provide insight and guidance to companies in FDA-regulated industries regarding their products, processes, innovation, product safety, and enforcement.
Who We Serve
We proudly support:
- Medical Device Manufacturers seeking compliance with QMSR and ISO 13485
- Startups and SMEs navigating FDA regulatory requirements for the first time
- Regulatory and Quality Professionals looking to expand their expertise
- Educational Institutions preparing the next generation of regulatory experts
Regulatory and Quality Information at Your Fingertips
We designed the Medical Devices and Pharma website to present critical industry information in a well-organized and easy-to-navigate format. We stay up-to-date with regulatory agency announcements and activities, so visitors to the site will see current information about medical devices, pharmaceuticals, biologics, combination products, and other regulated medical products.
Contact us
We are available to respond to regulatory questions, strategies, or managed projects. Do you have regulatory questions about your medical device or pharmaceutical product? Let us know – please contact us and we can provide regulatory guidance and advice for upcoming regulatory projects.
Regulatory and Quality Headlines
FDA Panel to Examine Pathogen-Agnostic Sequencing
November 19 advisory committee meeting will explore the scientific, clinical, and regulatory challenges of diagnostic...
A New Approach for Infectious-Disease Detection
Pathogen-Agnostic Sequencing and the Future of Infectious Disease PreparednessDetecting the Unknown. Connecting the...
FDA Approves Wilserdly for Advanced Breast Cancer
Genentech’s oral estrogen receptor antagonist significantly extends progression-free survival, accompanied by FDA...
FDA Pivots from Artificial Intelligence to Super Intelligence
A Regulatory Solution in Search of a ProblemFDA's implementation of a presidential terminology mandate raises questions...
Science, Politics, Special Interests, and FDA Independence
Former Insiders Challenge the Administration's Health AgendaFormer FDA Commissioner Marty Makary and former Kennedy adviser...
When Preventable Diseases Return
Diseases once brought under control through vaccination have returned with devastating consequences. Historical outbreaks...
Intersurgical 22mm Smoothbore Breathing Tubes and Systems
FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may...
FDA Early Alert: Teleflex/Arrow Guidewire
Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially...
Pimicotinib (Pimjetmi) for Tenosynovial Giant Cell Tumor
On November 10, 2026, the Food and Drug Administration approved pimicotinib (Pimjetmi, EMD Serono, Inc.), a kinase...
The Wolverine Peptide Stack: What We Know
Promoted for faster healing and injury recovery, two experimental peptides are attracting growing consumer interest despite...



